• Illumina, Quartzy, PerkinElmer, And More: News From April 2018

    Bio-IT World | April featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, Quartzy, PerkinElmer, and more.

    Apr 30, 2018

  • 10x Genomics Announces $125 Million Funding

    Bio-IT World News Brief | 10x Genomics announced a $125 million funding round that included $50 million Series D financing. It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity, and the SoftBank Group. The company complemented this financing with a new $75 million debt facility with Silicon Valley Bank.

    Apr 27, 2018

  • UK Commits A Billion Pounds To AI Development

    TOP500 | The British government and the private sector are investing close to £1 billion pounds to boost the country's artificial intelligence sector. The investment, which was announced on Thursday, is part of a wide-ranging strategy to make the UK a global leader in AI and big data.

    Apr 27, 2018

  • Cloud Over Troubled Data: Healing Bio-IoT

    Bio-IT World | As the healthcare and life-sciences sector has gradually accepted cloud-based data solutions, and as the sector's Big Data still grows ever Bigger, the Internet of Things (IoT) has become a driving force for health-IT practitioners and clinical researchers. All that data, after all, must come from somewhere—and must be constantly maintained and tempered by even more data.

    Apr 25, 2018

  • FAIR Data At The Right Time: What Researchers Are Saying About Data Stewardship

    Bio-IT World | There’s a movement afoot to make data more findable, accessible, interoperable and reusable. In a survey about data stewardship, Bio-IT World found that while data standards and sharing are widely considered important, most people still struggle with both.

    Apr 23, 2018

  • Bio-IT World Announces Finalists For 2018 Best Practices Awards

    Bio-IT World | The finalists for the 2018 Bio-IT World Best Practices competition were announced today. This year, 21 projects from 30 different organizations were chosen for the final round of competition.

    Apr 20, 2018

  • Cambridge Innovation Institute Announces Acquisition Of The AI World Conference & Expo, AI Trends

    Bio-IT World Brief | Cambridge Innovation Institute (CII), the parent company of Bio-IT World, announced the acquisition of Westborough, Massachusetts-based Trends Equity, which includes the properties of the annual AI World Conference & Expo and AI Trends media offerings.

    Apr 18, 2018

  • Data Science, AI, Genomics, & Much More: A Preview of #BioIT18

    Bio-IT World | Whether you are coming to tour the exhibit hall, watch the three awards programs, listen to the plenary speakers, participate in the Hackathon, or dig deep into the latest science you are sure to have a full and fruitful three days during the 2018 Bio-IT World Conference & Expo.

    Apr 13, 2018

  • Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development

    Diagnostics World News | Yesterday, FDA Commissioner Scott Gottlieb announced via Twitter new policies for the Administration he says are designed to "keep pace with fast-moving [next-generation sequencing] technologies." The three guidances focus solely on NGS and in vitro diagnostic development.

    Apr 13, 2018

  • HudsonAlpha’s Genomic Medicine Conference: Embracing A Brave New World

    Bio-IT World | Coinciding with the Institute’s 10-year anniversary, HudsonAlpha hosted their second Genomic Medicine Conference this week on their campus in Huntsville, Ala. For two and a half days researchers, geneticists and healthcare professionals told their stories about how genomic data has impacted their respective professions and how the data they have been collecting influences their patients.

    Apr 11, 2018

  • PerkinElmer Collaborates With Helix To Drive Innovation In Exome-Based Personal Genomics

    Bio-IT World Brief | PerkinElmer has announced a collaboration with Helix to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health management decisions. Tests developed as part of this collaboration will be available to customers of Helix’s expanding online marketplace for DNA-powered products.

    Apr 10, 2018

  • Dam Data: Health Systems, Machines, And Learning

    Bio-IT World Contributed Commentary | Increased use of electronic health records and other digital data has brought what amounts to a deluge of potential evidence, one that never ends. A “learning health system” can create the equivalent of a hydroelectric dam – a place to catch all of those raindrops in one place and release them in a coordinated, powerful way.

    Apr 9, 2018

  • Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: A Journey To Focus On Data And Digital

    Forbes | Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients' cells.

    Apr 9, 2018

  • This Company Can Encode Your Favorite Song In DNA—For $100,000

    MIT Technology Review | It's not cheap. But Twist Bioscience thinks storing data in genes could be the next big thing.

    Apr 6, 2018

  • Five Use Cases For AI and Machine Learning In Commercial Pharma

    Bio-IT World Contributed Commentary | Over the last decade, early business uses of Artificial Intelligence (AI), or machine learning, in life sciences have proven successful in drug discovery – predicting molecule-target bonding, identifying new biomarkers, and uncovering new drug indications. Now machine learning is gaining broader traction into other areas, including commercial operations, and transforming the way the industry collects, synthesizes, and uses data.

    Apr 4, 2018

  • Kite Pharma Veterans Launching New Firm To Develop Off-The-Shelf CAR-T

    STAT | Two former Kite Pharma executives unveiled Allogene Therapeutics, a new company trying to develop a suite of CAR-T therapy assets designed so that they do not need to be personalized for each cancer patient.

    Apr 3, 2018

  • Platypus: Deep Data Dives For Clinical Data Reviewer

    Bio-IT World | If you are creating a tool designed to give a sixth sense, of course you name it after a semiaquatic, egg-laying mammal endemic to eastern Australia. Not unlike the animal, Takeda’s Platypus is made up of various parts, specifically designed to meet the medical reviewer’s needs.

    Apr 2, 2018

  • Deceptive Cloud Efficiency: Do You Really Pay As You Use?

    Forbes | Cloud computing is often described as a "pay as you go" service, but that might not really be the case.

    Mar 30, 2018

  • Jennifer Doudna Joins Synthego Advisory Board

    Bio-IT World News Brief | Jennifer Doudna has joined Synthego’s advisory board. She will advise Synthego on a variety of product, partnership, and business strategy initiatives to help amplify the company's fast-growing impact in the genome engineering space. The advisory role builds on Doudna’s January 2017 individual investment in the company.

    Mar 29, 2018

  • AI Designs Organic Syntheses

    Nature | Software that devises effective schemes for synthetic chemistry has depended on the input of rules from researchers. A system is now reported in which an artificial-intelligence program learns the rules for itself.

    Mar 29, 2018